01 May 2017 | 8:17 AM
 

Parabolic Drugs Ltd. Share Price Live (BSE)
0

BSE Code: 533211 | NSE Symbol: PARABDRUGS
8.85
0.01
(0.12 %)
28 Apr 2017 | 04:01 PM
Change company
  • Open (Rs)
    8.23
  • Prev. close (Rs.)
    8.84
  • High (Rs.)
    9.00
  • Low (Rs.)
    8.23
  • 52W H (Rs.)
    10.39
  • 52W L (Rs.)
    3.75
  • Volume (Rs.)
    2780
  • MCap (Rs in Cr.)
    54.78
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-78.48
Operating Margin (%)
-399.23
Gross Profit Margin (%)
-486.72
Net Profit Margin (%)
-632.13
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

28 Apr 2017 - 11:59:00-Shares of drug maker Lupiun fell over 1 per cent on the Bombay Stock Exchange hitting 52-week low af...
27 Apr 2017 - 17:23:00-Pharma major Jubilant Life Sciences said that it has issued Commercial Papers (CPs) of Rs 75 crore...
27 Apr 2017 - 12:29:00-Drug major Dr Reddys Laboratories Ltd on Thursday said it has launched US health regulator approved ...
26 Apr 2017 - 17:21:00-Pharma major Cadila Healthcare Ltd on Wednesday said Zydus got final approval from the US health reg...

Announcements

14-Apr-2017
Parabolic Drugs Ltd. - Certificate From Practicing Company Secretary Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations
10-Apr-2017
Parabolic Drugs Ltd. - Compliance Certificate Under Regulation 7(3) For The Half Year Ended On 31St March 2017.
10-Apr-2017
Parabolic Drugs Ltd. - Shareholding for the Period Ended March 31 2017
10-Apr-2017
Parabolic Drugs Ltd. - Statement On Investor Complaint For The Quarter/Year Ended On 31St March 2017.
14-Mar-2017
Parabolic Drugs Ltd. - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended De

Religare Research

28 Apr 2017 | 05:39 PM
The Nifty index gained 2% led by good quarterly earnings and positive global cues. Even though the o...
28 Apr 2017 | 05:35 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
28 Apr 2017 | 03:38 PM
Akshaya Tritiya is a very popular festival that the Hindus celebrate every year. It is considered as...
28 Apr 2017 | 01:31 PM
Nifty futures has rolled around 66% vs 68%, with respect to last month, and the open interest for th...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
2,97,545 0.21 21.27 -0.07
2,97,545 0.21 21.39 -0.07

Shareholding Pattern

       
Promotors37.80%
Mutual Funds/UTI0.00%
FI/Banks0.57%
Insurance0.57%
FII8.06%
Government0.00%
Others14.79%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,390.00(-3.01)
3578
 Kovai Medical Center and Hospital Ltd.
1,215.00(-1.16)
11816
 Merck Ltd.
1,089.55(0.11)
3302
 Coral Laboratories Ltd.
1,037.00(0.74)
3462

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Parabolic Drugs Ltd.0.53-0.070.90
NIFTY(S&P CNX)203.25671.30666.05
BSE SENSEX508.882,068.841,976.89
BSE 500477.041,205.501,125.87

Corporate Details

Key Personal
No Data Available
Key Address
Registered Office
S.C.O 99-100 Top Floor Sector 17 - B,Chandigarh,Chandigarh

Tel:0172-3914646 3914647 3914638 3914668, Fax:0172-3914645

pdl.investors@parabolicdrugs.com
http://www.parabolicdrugs.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Parabolic Drugs Ltd. that will help you decide whether to buy, sell or hold Parabolic Drugs Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Parabolic Drugs Ltd.